Skip to main content
. Author manuscript; available in PMC: 2009 Feb 10.
Published in final edited form as: Neurology. 2006 Jan 10;66(1):35–40. doi: 10.1212/01.wnl.0000191300.38571.3e

Table 4.

Table 4a. Estrogen use among women study participants
ERT USED No ERT
Age 63.97 (9.98) years 74.4 (13.4) years
Education 11.6 (4.6) years 7.1 (8.4) years
AD 19 (5%) 361 (95%)
Unaffected 77 (21%) 289 (79%)
Table 4b. Estrogen use, APOE genotype and risk of AD among women study participants
ε4 ERT Number at Risk AD OR* 95%CI Significance
348 178 (51.1%) 1.0 -- Reference
+ 53 5 (9.4%) 0.2 0.1–0.5 p = 0.002
+ 305 185 (60.7%) 1.9 1.3–2.9 p < 0.001
+ + 43 14 (32.6%) 0.8 0.3–1.8 p = 0.533

Differences are statistically significant, p<0.001

*

= adjusted for age and education